Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Down 9.6% in May

Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Rating) was the recipient of a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 4,070,000 shares, a decline of 9.6% from the April 30th total of 4,500,000 shares. Based on an average daily volume of 1,720,000 shares, the […]

Related Keywords

Steven Keith Burke ,Piper Sandler ,Michel Dahan ,Akebia Therapeutics Inc ,Mirabella Financial Services ,Hightower Advisors ,Jpmorgan Chase Co ,Nasdaq ,Akebia Therapeutics ,Get Rating ,Keith Burke ,Financial Services ,Tower Advisors ,Akebia Therapeutics Daily ,Nasdaq Akba ,Nakba ,Medical ,Stocks ,Options ,Put ,Call ,